gip/glp-1 tirzepatide Tirzepatide, a dual receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction Systemic effects of tirzepatide dually
Description
Safety considerations include assessing for potential complications from the original surgery, ensuring adequate nutritional status, and evaluating kidney and liver function
Injection site reactions represent another category of commonly observed side effects
If using a vial, it is generally recommended to use it within 28 days of the first puncture, though you should check your specific pharmacy instructions
It is also commonly prescribed off-label (for non-FDA-approved use) to help with weight loss and weight management in people with obesity or who are overweight with weight-related medical conditions
Why does this matter
More gradual
